T. Rowe Price Exchange-Traded Funds, Inc. (TMED)
Management Company · XNAS · Series S000092023 · View on SEC EDGAR ↗
$35.90
As of Aug. 20, 2026
▼ -0.76 (-2.07%)
1-day change
$24.99 – $36.72
52-week range
Holdings data is not available for this fund yet.
On this page
- Price chart The fund's market price over time, with technical overlays.
- Performance Total return, volatility, drawdown and other risk metrics.
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
TMED Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
Performance as of Aug. 19, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▲ +23.45% | — |
| 3M | ▲ +23.45% | — |
| 6M | ▲ +22.87% | — |
| YTD | ▲ +23.34% | — |
| 1Y | ▲ +45.88% | — |
| 3Y | — | — |
| 5Y | — | — |
| Max since June 12, 2025 | ▲ +45.89% | — |
- Volatility 1Y
- 28.20%
- Volatility 3Y
- —
- Max drawdown 3Y
- —
- Beta 3Y
- —
- Sharpe 1Y*
- 2.38
Total return is shown once dividend history for this fund has been collected — price return alone would duplicate it misleadingly. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
- Last month (Mar 2026)
- +$1.4M
- Quarter ending Mar 2026
- +$4.4M
- Trailing 12 months
- +$18.2M
Apr 2025 – Mar 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 109 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| ELI LILLY & CO | 532457108 | $2.9M | 14.48 | 3,189 | EC | US |
| UNITEDHEALTH GROUP INC | 91324P102 | $1.3M | 6.54 | 4,898 | EC | US |
| THERMO FISHER SCIENTIFIC INC | 883556102 | $930K | 4.59 | 1,893 | EC | US |
| GILEAD SCIENCES INC | 375558103 | $839K | 4.14 | 6,020 | EC | US |
| ABBOTT LABORATORIES | 002824100 | $793K | 3.91 | 7,720 | EC | US |
| DANAHER CORP | 235851102 | $553K | 2.73 | 2,918 | EC | US |
| MEDTRONIC PLC | G5960L103 | $454K | 2.24 | 5,245 | EC | IE |
| ALNYLAM PHARMACEUTICALS INC | 02043Q107 | $418K | 2.06 | 1,262 | EC | US |
| STRYKER CORP | 863667101 | $406K | 2.00 | 1,235 | EC | US |
| DYNE THERAPEUTICS INC | 26818M108 | $380K | 1.88 | 20,969 | EC | US |
| WATERS CORP | 941848103 | $355K | 1.75 | 1,192 | EC | US |
| BECTON DICKINSON AND CO | 075887109 | $346K | 1.71 | 2,202 | EC | US |
| AGILENT TECHNOLOGIES INC | 00846U101 | $341K | 1.69 | 2,996 | EC | US |
| ELANCO ANIMAL HEALTH INC | 28414H103 | $321K | 1.59 | 13,428 | EC | US |
| HUMANA INC | 444859102 | $318K | 1.57 | 1,835 | EC | US |
| CYTOKINETICS INC | 23282W605 | $311K | 1.54 | 4,722 | EC | US |
| WEST PHARMACEUTICAL SERVICES | 955306105 | $300K | 1.48 | 1,198 | EC | US |
| BOSTON SCIENTIFIC CORP | 101137107 | $298K | 1.47 | 4,745 | EC | US |
| ASCENDIS PHARMA A/S - ADR | 04351P101 | $282K | 1.39 | 1,235 | EC | DK |
| BIOGEN INC | 09062X103 | $255K | 1.26 | 1,390 | EC | US |
| VAXCYTE INC | 92243G108 | $240K | 1.19 | 4,136 | EC | US |
| IMMUNOME INC | 45257U108 | $233K | 1.15 | 10,669 | EC | US |
| METTLER-TOLEDO INTERNATIONAL | 592688105 | $224K | 1.11 | 178 | EC | US |
| CENCORA INC | 03073E105 | $215K | 1.06 | 685 | EC | US |
| APELLIS PHARMACEUTICALS INC | 03753U106 | $208K | 1.03 | 5,162 | EC | US |
| REGENERON PHARMACEUTICALS | 75886F107 | $206K | 1.02 | 267 | EC | US |
| DEXCOM INC | 252131107 | $204K | 1.01 | 3,251 | EC | US |
| CVS HEALTH CORP | 126650100 | $194K | 0.96 | 2,698 | EC | US |
| MOONLAKE IMMUNOTHERAPEUTICS | 61559X104 | $181K | 0.89 | 9,719 | EC | KY |
| INSULET CORP | 45784P101 | $169K | 0.83 | 803 | EC | US |
| ADAPTIVE BIOTECHNOLOGIES | 00650F109 | $168K | 0.83 | 12,084 | EC | US |
| BICARA THERAPEUTICS INC | 055477103 | $165K | 0.82 | 8,310 | EC | US |
| BIONTECH SE-ADR | 09075V102 | $163K | 0.80 | 1,829 | EC | DE |
| IMMATICS NV | N44445109 | $161K | 0.79 | 16,368 | EC | NL |
| REPLIGEN CORP | 759916109 | $160K | 0.79 | 1,359 | EC | US |
| COOPER COS INC/THE | 216648501 | $157K | 0.78 | 2,197 | EC | US |
| SHATTUCK LABS INC | 82024L103 | $155K | 0.77 | 24,111 | EC | US |
| IDEXX LABORATORIES INC | 45168D104 | $149K | 0.74 | 266 | EC | US |
| XENON PHARMACEUTICALS INC | 98420N105 | $149K | 0.73 | 2,558 | EC | CA |
| SAREPTA THERAPEUTICS INC | 803607100 | $148K | 0.73 | 6,817 | EC | US |
| BRISTOL-MYERS SQUIBB CO | 110122108 | $148K | 0.73 | 2,432 | EC | US |
| MOLINA HEALTHCARE INC | 60855R100 | $144K | 0.71 | 1,082 | EC | US |
| APOGEE THERAPEUTICS INC | 03770N101 | $140K | 0.69 | 1,658 | EC | US |
| CG ONCOLOGY INC | 156944100 | $137K | 0.68 | 2,028 | EC | US |
| AGIOS PHARMACEUTICALS INC | 00847X104 | $132K | 0.65 | 3,906 | EC | US |
| INCYTE CORP | 45337C102 | $132K | 0.65 | 1,398 | EC | US |
| KYMERA THERAPEUTICS INC | 501575104 | $125K | 0.62 | 1,497 | EC | US |
| NOVO-NORDISK A/S-SPONS ADR | 670100205 | $118K | 0.58 | 3,200 | EC | DK |
| CABALETTA BIO INC | 12674W109 | $117K | 0.58 | 43,630 | EC | US |
| ALIGN TECHNOLOGY INC | 016255101 | $109K | 0.54 | 634 | EC | US |
Page 1
of 3
← Previous
Next →
Institutional owners (13F) 4 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| COMMONWEALTH EQUITY SERVICES, LLC | $329,060 | 38.98% | 9,635 | Shares | June 30, 2026 |
| Essex Financial Services, Inc. | $310,790 | 36.82% | 9,100 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $203,482 | 24.11% | 5,958 | Shares | June 30, 2026 |
| FLOW TRADERS U.S. LLC | $814 | 0.10% | 23,827 | Shares | June 30, 2026 |
Peer funds
More from this issuer
| Fund | AUM |
|---|---|
| TAGG T. Rowe Price Exchange-Traded F… | $1.9B |
| TOUS T. Rowe Price Exchange-Traded F… | $1.4B |
| TBUX T. Rowe Price Exchange-Traded F… | $1.1B |
| THYF T. Rowe Price Exchange-Traded F… | $815.6M |
| TFLR T. Rowe Price Exchange-Traded F… | $613.4M |
| TOTR T. Rowe Price Exchange-Traded F… | $561.8M |
| TAXE T. Rowe Price Exchange-Traded F… | $156.7M |
| TIER T. Rowe Price Exchange-Traded F… | $27.6M |
| THYM T. Rowe Price Exchange-Traded F… | $25.3M |
| TMNL T. Rowe Price Exchange-Traded F… | $22.6M |
Similar by size
| Fund | AUM |
|---|---|
| SCAP Series Portfolios Trust | $20.4M |
| MRCP PGIM Rock ETF Trust | $20.5M |
| WANT Direxion Shares ETF Trust | $20.5M |
| AVGB AMERICAN CENTURY ETF TRUST | $20.5M |
| JHAI Janus Detroit Street Trust | $20.5M |
| JULP PGIM Rock ETF Trust | $20.1M |
| GDOC Goldman Sachs ETF Trust | $20.1M |
| TPLS Thornburg ETF Trust | $20.1M |
| SETH ProShares Trust | $20.1M |
| SEPP PGIM Rock ETF Trust | $20.0M |